Valley Hope of Grapevine is a licensed detox provider in Grapevine, TX, listed in the SAMHSA treatment directory. Its team manages alcohol withdrawal, including the delirium tremens that can peak in the first two to four days. Benzodiazepine detox here is handled on a gradual, structured taper to prevent seizures rather than stopping abruptly. For opioid dependence it provides medically supervised detox, and it can pair that with medication to ease withdrawal. Buprenorphine (Suboxone) is offered to reduce opioid withdrawal and lower relapse and overdose risk. Stimulant detox focuses on rest, nutrition, and mental health support through the acute crash. Detox is delivered in a 24 hour residential setting with staff on site around the clock. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 984-9911
and we will help you confirm openings, insurance, and next steps.
Detox services
Alcohol DetoxificationBenzodiazepines DetoxificationCocaine DetoxificationMethamphetamines detoxificationOpioids detoxificationMedication routinely used during detoxification
Level of care
OutpatientResidential/24-hour residentialOutpatient day treatment or partial hospitalizationIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentResidential detoxificationLong-term residentialShort-term residential
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
IHS/Tribal/Urban (ITU) fundsFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-payment
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState department of healthThe Joint Commission
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
2100 North State Highway 360, Suite 1904, Grand Prairie, TX 75050
Alcohol DetoxificationBenzodiazepines DetoxificationCocaine DetoxificationFederal, or any government funding for substance use treatment programsMedicare